Tecfidera and the Gut Microbiota

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 6, 2015

Primary Completion Date

June 12, 2017

Study Completion Date

June 12, 2017

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

dimethyl fumarate

As per the prevailing local label.

DRUG

injectable MS DMT

As described above.

Trial Locations (7)

1478

Research site, Lørenskog

2609

Research Site, Lillehammer

3019

Research site, Drammen

4011

Research site, Stavanger

5021

Research site, Haukeland

6412

Research site, Molde

0450

Research site, Oslo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY